SUMO2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.210200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.040800E-01
Normal-vs-Stage2
8.883800E-01
Normal-vs-Stage3
8.632400E-01
Normal-vs-Stage4
5.017200E-01
Stage1-vs-Stage2
4.693800E-01
Stage1-vs-Stage3
8.299800E-01
Stage1-vs-Stage4
4.165600E-02
Stage2-vs-Stage3
8.433600E-01
Stage2-vs-Stage4
4.760000E-01
Stage3-vs-Stage4
6.232200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.923600E-01
Normal-vs-AfricanAmerican
9.431400E-01
Normal-vs-Asian
9.862800E-01
Caucasian-vs-AfricanAmerican
9.032800E-01
Caucasian-vs-Asian
7.764200E-01
AfricanAmerican-vs-Asian
9.236200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.097400E-01
Normal-vs-Female
9.475400E-01
Male-vs-Female
8.100800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.770800E-01
Normal-vs-Age(41-60Yrs)
5.512600E-01
Normal-vs-Age(61-80Yrs)
6.920800E-01
Normal-vs-Age(81-100Yrs)
7.068200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.063200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.961000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.472400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.972700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.194200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.616600E-01
Normal-vs-Daily Drinker
4.862000E-01
Normal-vs-Weekly Drinker
7.152200E-01
Normal-vs-Occasional Drinker
6.425600E-01
Normal-vs-Social Drinker
9.421400E-01
Non Drinker-vs-Daily Drinker
4.384600E-01
Non Drinker-vs-Weekly Drinker
9.538000E-01
Non Drinker-vs-Occasional Drinker
1.242770E-01
Non Drinker-vs-Social Drinker
6.447800E-01
Daily Drinker-vs-Weekly Drinker
5.338600E-01
Daily Drinker-vs-Occasional Drinker
3.373700E-02
Daily Drinker-vs-Social Drinker
2.511800E-01
Weekly Drinker-vs-Occasional Drinker
1.658000E-01
Weekly Drinker-vs-Social Drinker
6.276800E-01
Occasional Drinker-vs-Social Drinker
3.311000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.860800E-01
Normal-vs-Grade 2
7.477400E-01
Normal-vs-Grade 3
7.143400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.009000E-01
Grade 1-vs-Grade 3
3.371600E-01
Grade 1-vs-Grade 4
4.860800E-01
Grade 2-vs-Grade 3
3.766400E-01
Grade 2-vs-Grade 4
7.477400E-01
Grade 3-vs-Grade 4
7.143400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.628800E-01
Normal-vs-NonDiabetic
9.706600E-01
Diabetic-vs-NonDiabetic
5.262400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.400800E-01
Normal-vs-NoPancreatitis
9.349800E-01
Pancreatitis-vs-NoPancreatitis
5.694400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.663200E-01
Normal-vs-N1
8.882600E-01
N0-vs-N1
5.300800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.450800E-01
Normal-vs-TP53-NonMutant
7.695600E-01
TP53-Mutant-vs-TP53-NonMutant
1.464480E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
